Breast Dose in Young Women Treated for Hodgkin Lymphoma Between 2007 and 2018: A Single Institutional Study

Autor: C. Hague, S. Astley, Marianne C. Aznar, John Radford, S. Tenant, Richard A Cowan, J.L.R. Williams, Sacha J Howell, H.C. Chamberlin

Publikováno v: Chamberlin, H C, Astley, S, Cowan, R, Hague, C, Howell, S J, Radford, J A, Tenant, S, Williams, J L R & Aznar, M C 2021, ' Breast Dose in Young Women Treated for Hodgkin Lymphoma Between 2007 and 2018 : A Single Institutional Study ', International journal of radiation oncology, biology, physics, vol. 111, no. 3, pp. e304-e305 . https://doi.org/10.1016/j.ijrobp.2021.07.953

PURPOSE/OBJECTIVE(S): Women receiving supradiaphragmatic radiotherapy (RT) for Hodgkin Lymphoma (HL) aged ≤ 36y have a greater risk of breast cancer (BC) than the general population. Although RT fields have reduced in recent years, breast tissue (B

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04b90e78143dadde46ed8fec7bc650dc
https://doi.org/10.1016/j.ijrobp.2021.07.953

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.